Literature DB >> 11863302

Effusive constrictive pericarditis due to rheumatoid arthritis revealed by pericardiocentesis with simultaneous pressure recording--a case report.

Tomohiro Harada1, Teruhiko Aoyagi, Yoko Endo, Kansei Uno, Katsu Takenaka, Fumitaka Nakamura, Makoto Sonoda, Toshiyuki Takahashi, Tadashi Yamazaki, Yukio Hiroi, Minoru Ohno, Yasunobu Hirata, Ryozo Nagai.   

Abstract

A 59-year-old man had a history of rheumatoid arthritis. He presented with incurable pericardial effusion. He was repeatedly treated with pericardiocentesis with only transient attenuation of his symptoms because the underlying pericardial constriction had been overlooked. This time the authors diagnosed effusive constrictive pericarditis due to rheumatoid arthritis using the hemodynamic findings observed before and after pericardiocentesis.

Entities:  

Mesh:

Year:  2002        PMID: 11863302     DOI: 10.1177/000331970205300115

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

Review 1.  Effusive-constrictive pericarditis.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi; Jae K Oh
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  Liver chemistry abnormalities and leg oedema in rheumatoid arthritis.

Authors:  Eva Marianne van Soest; Anho Liem; Jende van Zeben
Journal:  BMJ Case Rep       Date:  2018-04-19

3.  Seronegative rheumatoid arthritis: a rare cause of effusive-constrictive pericarditis requiring pericardiectomy.

Authors:  Alan Soo; Alastair Graham
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-09

4.  Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients.

Authors:  Mehmet Kabukcu; Fatih Demircioglu; Ekrem Yanik; Ibrahim Basarici; Filiz Ersel
Journal:  Tex Heart Inst J       Date:  2004

5.  Surgical management of effusive constrictive pericarditis.

Authors:  Fuat Buyukbayrak; Eray Aksoy; Serpil Tas; Kaan Kirali
Journal:  Cardiovasc J Afr       Date:  2013-09-16       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.